• Home
  • People
    • Matthew Meyerson
    • Scientific Staff
    • Research Fellows
    • Students
    • Lab Alumni
  • Research
    • Cancer Genomic Technology
    • Genomics of Lung and Other Cancers
    • Lung Cancer Biology
    • Genome-inspired Cancer Drug Discovery
    • Cancer Microbiome
    • Ribonucleotides and the Inflammatory Response
  • Datasets & Tools
  • Publications
    • Primary Articles
    • Lab and Collaborative Articles
    • Review Articles
  • News
  • Contact
  • Lab Only
    • Whiteboard
    • Questions/Help
    • Protocols
    • Calendar
    • Interesting Science
Meyerson Lab - Cancer Genomics and Genome-Inspired Discovery

Meyerson Laboratory
CANCER GENOMICS AND GENOME-INSPIRED DISCOVERY

Ribonucleotides and the Inflammatory Response

Role of ADAR1 in interferon-activated cancer cells. Our identification of the RNA adenosine deaminase gene ADAR1 as a genetic dependency in some lung cancer cell lines led to the finding that an elevated interferon gene expression signature is a biomarker for the vulnerability of cancer cells to ADAR1 loss (Gannon, et al., 2018). We are working to understand the relationship between elevated interferon gene expression and ADAR1 deletion, and how ADAR1 can be exploited as a therapeutic target in cells expressing high levels of interferon-stimulated genes.
Citations of the above images
 HOME | PEOPLE | RESEARCH | PUBLICATIONS | PICTURES | NEWS | LAB ONLY | CONTACT

©2015 Meyerson Laboratory Dana-Farber Cancer Institute